Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 18 clinical trials
Neurovascular Coupling and Autonomic Neuropathy in Type 2 Diabetes

Diabetes is a growing global health care challenge. Diabetes patients may also suffer from cardiovascular autonomic neuropathy (CAN) which may affect cerebral perfusion. The main purpose of this

Accepts healthy volunteers
  • 0 views
  • 04 Jun, 2022
  • 2 locations
Autonomic Small Fiber Neuropathy and Ehlers Danlos Syndromes - Prospective Study and Registry (ProANS)

We examine patients with different autonomic neuropathies and Ehlers Danlos syndromes compared to healthy controls at three different points over time (baseline, after 3 months and after 1.5 years) to gain knowledge about the course of this disease and understand its pathophysiology, with a focus on Small Fiber neuropathy.

ehlers-danlos syndrome
  • 183 views
  • 26 May, 2022
  • 1 location
BAROSTIM THERAPY™ In Heart Failure With Preserved Ejection Fraction (HFpEF)

The purpose of this registry (NCT02876042) is to evaluate the effect of BAROSTIM THERAPY with the BAROSTIM NEO system in the commercial setting in subjects recently implanted under the CE-Marked indication for resistant hypertension that also have evidence of heart failure with preserved ejection fraction (HFpEF).

heart failure with preserved ejection fraction
diastolic dysfunction
heart failure
hypertension
ejection fraction
  • 29 views
  • 27 Jan, 2022
  • 4 locations
BAROSTIM THERAPY™ In Resistant Hypertension

The purpose of this registry (NCT02880631) is to evaluate the effect of BAROSTIM THERAPY with the BAROSTIM NEO System in the commercial setting in subjects recently implanted under the CE-Marked indication for resistant hypertension.

resistant hypertension
hypertension
diuretics
systolic blood pressure
hypertensive medication
  • 22 views
  • 27 Jan, 2022
  • 14 locations
BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction (HFrEF)

The purpose of this registry (NCT02880618) is to evaluate the effect of BAROSTIM THERAPY with the BAROSTIM NEO System in the commercial setting in subjects recently implanted under the CE-Marked indication for heart failure with reduced ejection fraction (HFrEF).

heart failure
ejection fraction
  • 34 views
  • 27 Jan, 2022
  • 5 locations
Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome

Postural Tachycardia Syndrome (POTS) is the most common autonomic disorder and is estimated to affect 3,000,000 individuals in the United States, with 80-85% of patients being women. The condition is characterized by a rapid increase in heart rate (HR) that occurs on standing, and chronic symptoms of cerebral hypoperfusion leading …

  • 0 views
  • 16 May, 2022
  • 1 location
Early Detection of Long-term Diabetic Complications in Children and Adolescents With Type 1 Diabetes

Aims: To investigate early markers of arterial stiffness and nerve dysfunction and the association to an extended glucose metabolic profile comprising glucose control (current and past), glucose variability and insulin sensitivity in children and adolescents with type 1 diabetes (T1D). Background: Most Danish children and adolescents with T1D do not …

nephropathy
diabetes
insulin
diabetic complications
  • 0 views
  • 26 May, 2022
  • 1 location
The Natural History of Familial Dysautonomia

The study will collect clinical information from patients with FD and allow them to give blood to help develop biological markers of the disease to aid diagnosis and treatment. This is a non-invasive, non-interventional, observation study that poses only minimal risk for participants. The study will document the clinical features …

  • 63 views
  • 20 Apr, 2022
  • 2 locations